Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2012-08-31
2013-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Variability in Perimetry Study
NCT01051739
Test-retest Reliability of Two Measurements of the Visual System
NCT03242421
Study on the Effectiveness and Safety of VRT in Patients With Visual Field Defects
NCT06914505
Visual Remapping to Aid Reading With Field Loss
NCT03848663
Non-inferiority Study for Visual Field Measurements Using a Virtual Reality Device
NCT04010383
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Visit 2: 1 to 2 days after baseline. The intervention group gets 1 practice test per eye. Then both groups get a regular automated visual field Visit 3: 1 to 2 weeks after baseline. The intervention group gets 1 practice test per eye. Then both groups get a regular automated visual field.
Study Ends, patient gets seen by the patient.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
No practice tests are performed in this arm
No interventions assigned to this group
Practice Program
At the 3 study visits exposed to a training session (simulated visual field test on a computer).
Visit 1 they get 2 simulated tests tests per eye. At visits 2 and 3 they get 1 simulated test per eye. Each simulated test takes 3-15 minutes
Practice program
Each practice session (simulated visual field test on computer) takes 3-15 minutes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Practice program
Each practice session (simulated visual field test on computer) takes 3-15 minutes
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Referred to the glaucoma clinic for examination due to suspected glaucoma or glaucoma diagnosis
* No more than 1 automated visual field test within the last 4 years
Exclusion Criteria
* patients with neck problems that prevent them from using the field analyzer properly
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oftalmologia Hospital Sotero del Rio
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eugenio A. Maul
Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Sótero del Río
Santiago, Puente Alto, Chile
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Oftalmo_Glaucoma_002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.